A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency: a Stepped Wedge Cluster Randomized Control Trial (RCT)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Anemia
- Sponsor
- The University of Texas Health Science Center, Houston
- Enrollment
- 450
- Locations
- 1
- Primary Endpoint
- Percentage of subjects who have correct diagnosis of cause of low hemoglobin
- Status
- Recruiting
- Last Updated
- 4 months ago
Overview
Brief Summary
The purpose of this study is to measure the evidence-based intervention's (EBIs) impact on patient safety and efficiency, to assess the EBIs implementation by measuring acceptability, appropriateness, cost, fidelity, penetration, and sustainability and to identify the facilitators and barriers that influence the degree of implementation of these EBIs.
Investigators
Eric Thomas
Professor
The University of Texas Health Science Center, Houston
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Percentage of subjects who have correct diagnosis of cause of low hemoglobin
Time Frame: within 6 months from baseline
Percentage of subjects who have correct diagnosis of cause of low hemoglobin
Percentage of subjects who have correct diagnosis of cause of low glomerular filtration
Time Frame: within 6 months from baseline
Percentage of subjects who have correct diagnosis of cause of low glomerular filtration
Secondary Outcomes
- Time until diagnosis(initial abnormal test result to the day the diagnosis was communicated to the patient (about 1-6 months))
- Percentage of tests appropriately utilized(within 6 months from baseline)
- Cost of treatment(from baseline to 6 months)
- Number of primary care physicians (PCPs) who find the intervention as acceptable assessed by survey of PCPs(12 weeks after PCP's patient enrolled)
- Number of PCPs who find the intervention appropriate as assessed by survey of PCPs(12 weeks after PCP's patient enrolled)
- Number of PCPs who find the intervention feasible as assessed by survey of PCPs(12 weeks after PCP's patient enrolled)
- Fidelity as assessed by the percentage of participants who moved through each step of the diagnostic process needed for their diagnosis(6 months)
- Penetration as assessed by the percentage of participants with abnormal tests who receive the intervention(6 months)
- Sustainability as assessed by number of clinics that continued the intervention(2.5 years)
- Patient activation as assessed by the short form of the Patient Activation Measure (PAM)(between 1 to 6 months)
- Number of clinics with more facilitators than barriers(6 months)